Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

TYRABearishAnalyst Target Updateanalyst

High materiality7/10

Tyra Biosciences price target lowered to $40 from $50 at Oppenheimer

Sep 22, 2026, 4:50 PM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Analyst downgrade signals near-term downside risk; risk-reward unattractive at current price despite upside from 40 target.

AI summary

What happened, with direct paths to the underlying reporting

Oppenheimer cuts TYRA target to $40; current price around $25.65; implies downside bias.

Target lowered to $40; price 25.65; indicates bearish bias.

Key facts

01
Target: $40
02
Posted price: $25.65
03
Analyst firm: Oppenheimer

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.